FDA Approves 11 Philip Morris Zyn Ultra Pouches
By Josh Beckerman
The Food and Drug Administration authorized the marketing of 11 of Philip Morris International's Zyn Ultra nicotine pouches, while others remain under review.
The FDA approved 10 products with 9-milligram nicotine concentrations and one with an 11-milligram concentration. Other 11-milligram items are under review.
In June, the FDA granted modified risk orders for 20 Zyn pouches, allowing the product to carry language that "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."
To date, the FDA has authorized 43 nicotine pouches, including 23 under a pilot program intended to streamline the review process, the agency said Friday.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
August 21, 2026 16:00 ET (20:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
United States